SCHEMBL30515134

SCHEMBL30515134

CCc1ccc(-c2nc(CCOc3ccc4c(c3)CC[C@H]4CC(=O)O)c(CC)o2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 20/20 1.00
PPARG P37231 19/20 1.00
PPARD Q03181 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4680723 1.00 PPARA (1.00) PPARAPPARGPPARD
SCHEMBL18095652 1.00 PPARA (1.00) PPARAPPARGPPARD
SCHEMBL9909947 0.95 PPARG (0.91) PPARAPPARG
SCHEMBL9909944 0.95 PPARG (0.91) PPARAPPARG
SCHEMBL20222915 0.93 PPARG (1.00) PPARAPPARG
SCHEMBL9910103 0.93 PPARG (0.87) PPARAPPARG
SCHEMBL9910077 0.93 PPARG (0.87) PPARAPPARG
SCHEMBL3808617 0.93 PPARG (0.87) PPARAPPARG
SCHEMBL15267315 0.93 PPARG (0.87) PPARAPPARG
SCHEMBL9910024 0.93 PPARG (0.87) PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054309-A9 METHODS OF IDENTIFYING AND TREATING PATIENTS HAVING NEURODEGENERATIVE DISEASE BASED ON PLASMA BIOMARKER LEVELS T3D THERAPEUTICS, INC. (US) 2025-05-01 WO disclosed
WO-2025054309-A1 METHODS OF IDENTIFYING AND TREATING PATIENTS HAVING NEURODEGENERATIVE DISEASE BASED ON PLASMA BIOMARKER LEVELS T3D THERAPEUTICS, INC. (US) 2025-03-13 WO disclosed
WO-2025024308-A1 METHODS OF TREATING ENDOTHELIAL CELL AND AMYLOID RELATED BRAIN DISORDERS USING NOVEL COMPOUNDS AND ANTIBODIES T3D THERAPEUTICS, INC. (US) 2025-01-30 WO disclosed
WO-2023146818-A2 METHODS OF TREATING AMYLOID RELATED BRAIN DISORDERS USING NOVEL COMPOUNDS AND ANTIBODIES T3D THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed